scispace - formally typeset
M

Maikel P. Peppelenbosch

Researcher at Erasmus University Rotterdam

Publications -  610
Citations -  25498

Maikel P. Peppelenbosch is an academic researcher from Erasmus University Rotterdam. The author has contributed to research in topics: Signal transduction & Cancer. The author has an hindex of 74, co-authored 565 publications receiving 21791 citations. Previous affiliations of Maikel P. Peppelenbosch include University of Amsterdam & University Medical Center Groningen.

Papers
More filters
Journal ArticleDOI

An ex vivo readout for evaluation of dendritic cell-induced autologous cytotoxic T lymphocyte responses against esophageal cancer

TL;DR: A practical, patient-specific autologous readout assay for pre-clinical testing of DC-mediated cytotoxic responses is introduced and it is demonstrated that the use of autologously tumor RNA as a strategy for raising cytot toxic responses against multiple tumor antigens could be effective for treating esophageal cancer.
Journal ArticleDOI

Dichotomy in Hedgehog signaling between human healthy vessel and atherosclerotic plaques.

TL;DR: A dichotomy between healthy vessels and atherosclerotic plaques with respect to the activation status of the HH pathway exists, and it is tempting to suggest that downregulation of HH signaling contributes to long-term plaque stability.
Journal ArticleDOI

Efficacy of Different Endoscopic Stents in the Management of Postoperative Biliary Strictures: A Systematic Review and Meta-analysis.

TL;DR: F CSEMS-M is more favorable in the management of BBS comparing with MPS or FCSEMS-C, and the biodegradable stent may be a promising option but currently available data is insufficient to draw a firm conclusion.
Journal ArticleDOI

Systems medicine approaches for peptide array-based protein kinase profiling: progress and prospects

TL;DR: The authors discuss the potential of peptide array-based kinome profiling for evaluating cellular signalling in the context of drug discovery through analysis of cellular signalling without a priori assumptions to possibly influenced pathways.